乳腺癌中的p53/miRNA轴
Reza Shah Hosseini1, Seyed Mohammad Nouri2, Pooja Bansal3,4
1Istanbul Medipol University, Faculty of Medicine, Istanbul, Turkey.
DNA and cell biology
|October 18, 2024
概括
在乳腺癌 (BC) 的发展中,p53/microRNA (miRNA) 轴至关重要. 理解这种相互作用可能会导致新的BC治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌 (BC) 是一个普遍的全球健康问题.
- 遗传和环境因素有助于BC的发展.
- 作为关键的瘤抑制剂的p53基因与癌症途径中的微RNA (miRNA) 相互作用.
研究的目的:
- 探索乳腺癌中p53基因和miRNAs之间的调控关系.
- 阐明p53/miRNA轴在BC进展和预防中的作用.
- 为了确定BC治疗的潜在治疗点.
主要方法:
- 关于p53,miRNA和乳腺癌的研究的文献综述.
- 对p53-miRNA相互作用背后的分子机制的分析.
- 检查受p53和miRNA失调影响的信号通路.
主要成果:
- 突变或p53的降解会破坏miRNA的表达,增加BC风险.
- 失调的miRNAs可以负面调节p53,影响癌症的发展.
- p53/miRNA轴在BC病变发生过程中起着至关重要的作用.
结论:
- p53/miRNA轴是乳腺癌的一个重要途径.
- 针对这一轴为新型BC治疗策略提供了潜力.
- 对p53-miRNA相互作用的进一步研究对于临床应用是有必要的.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K


